Topotecan Decreases the Expression of Programmed Death-Ligand 1 in Glioblastoma Cell Lines; Implications for Immunotherapy
Matters
doi 10.19185/matters.201709000008
Full Text
Open PDFAbstract
Available in full text
Date
October 5, 2017
Authors
Publisher
Sciencematters